Government Asked to Guarantee Availability and Prices of Reagents
A number of hospitals in many parts of the country have begun to implement the government’s regulation on the price ceiling for the polymerase chain reaction (PCR) nasopharyngeal swab test.
/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2020%2F08%2F1f1438af-4b82-4fe1-bae1-5e5515babaf9_jpg.jpg){kind=logo}
A journalist had his saliva sampled by a health worker in a test using the polymerase chain reaction method at the Press Council Building, Central Jakarta, Wednesday (12/8/2020).
JAKARTA, KOMPAS – A number of hospitals in many parts of the country have begun to implement the government’s regulation on the price ceiling for the polymerase chain reaction (PCR) nasopharyngeal swab test. However, the price disparities of reagents have hampered the implementation of the price ceiling policy.
The head of the health insurance department of the Indonesian Hospital Association, Daniel Wibowo, said in Jakarta on Tuesday (6/10/2020) that a number of hospitals had set the price of the PCR test at Rp 900,000 (US$62) according to the government’s price ceiling. To ensure that all hospitals can follow the price limit, the government should be able to eliminate the disparities of the reagent prices.